Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Startup Spotlight: Making cancer vaccines as unique as a patient’s cancer

  • Meghana Keshavan

By Meghana Keshavan Jan. 5, 2017

Reprints
STAT SPOTLIGHT
Alex Hogan/STAT

Cancer vaccines are experiencing a bit of a resurgence, as we see in the new $70 million fundraise from Neon Therapeutics.

The startup, based in Cambridge, Mass., is developing cancer vaccines that target neoantigens — that is, substances that are unique to the surface of cancer cells.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Medical device companies now need to prove to FDA…
Medical device companies now need to prove to FDA they’re protected against cyber attacks
Shortage of monkeys for early-stage research jeopardizes timelines for…
Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Pressure is building on pharma and biotech companies to…
Pressure is building on pharma and biotech companies to take climate action
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO

Recommended Stories